The informed consent was obtained from all subjects and the study protocol was approved by the ethics committee of the first affiliated hospital, Jilin University. were not significantly different from healthy ARRY-380 (Irbinitinib) controls. Conclusions Our study provides the first evidence that rs12423190 polymorphism of the gene is significantly associated with an increased risk of gastric atrophy in infected Chinese Han population, suggesting that rs12423190 polymorphism could be used as a useful marker of genetic susceptibility to gastric atrophy among infected subjects. The biological roles of this polymorphism require a further investigation. Background Gastric cancer is the most common malignancy of gastrointestinal tract in East Asian populations and the third most common cause of cancer-related deaths in China [1,2]. (is estimated to inhabit at least half of the worlds human population, just few subjects ARRY-380 (Irbinitinib) develop to gastric precancerous lesions and adenocarcinoma. The extent of gastric damages induced by infection Rabbit Polyclonal to JAB1 seems to vary from one subject to another, suggesting that the combination of host genetic traits and bacterial virulence plays important roles in long-term outcomes of infection [5-7]. Several studies have provided evidences that infection with cagA-positive associates with higher grades of gastric inflammation and is more virulent than the cagA-negative strains [8]. The CagA protein is delivered into gastric epithelial cells via the bacterial type IV secretion system, where it undergoes tyrosine phosphorylation by Src and Abl kinases. Tyrosine-phosphorylated CagA then acquires capability to interact with and deregulate SHP-2 phosphatase, a bona-fide oncoprotein [9]. The formation of cagA/SHP-2 complex induces abnormal proliferation and migration of gastric epithelial cells, consequently resulting in gastric atrophy and gastric carcinoma [10-12]. In addition, gain-of-function mutations of the SHP-2 have recently been found in human malignancies ARRY-380 (Irbinitinib) [13-15]. Kim et al also revealed that gastric cancers displayed higher levels of SHP-2 protein compared to normal cells, suggesting that neo-expression of this signalling protein in cells might play a role in the gastric carcinogenesis [16]. Since the protein-tyrosine phosphatase nonreceptor-type ARRY-380 (Irbinitinib) 11 (may mediate the interaction of this protein with its substrates and affect its regulatory role ARRY-380 (Irbinitinib) in various cell signalling events, such as mitogenic activation, metabolic control, transcription regulation, cell migration, and malignant transformation in infected subjects. The gene is on chromosome 12, containing 16 exons. Several singleCnucleotide polymorphisms (SNPs) rs11066322, rs11066320 and rs2301756 have been identified in Caucasian females to be associated with apoB levels and LDL-C levels [17]. Another study demonstrated that the rs11066322 was associated with increased plasma HDL-C levels [18]. These results suggested that genetic variants influencing SHP-2 activities may modulate biological functions of the protein. In gastric cancer, Japanese group has found that a prevalent SNP in intron3 (rs2301756) was associated with an increased risk of gastric atrophy in Japanese population with infection [19-22]. The aim of the present study is to determine whether polymorphisms of gene are associated with clinical outcomes of infection in Chinese population. Methods Study populations Four hundred and fourteen Gastric cancer cases were selected from the department of gastric and colorectal surgery, the First Hospital, Jilin University, from 2008 to 2010. All patients underwent tumor resection with histologically confirmed diagnosis of gastric adenocarcinoma. The gastric atrophy individuals and health controls were recruited from the healthy check-up centre of the same hospital from 2009 to 2010. A total 1080 persons (630 males and 450 females, aged 35 to 80 years old) participated in the study without history of cancer. The examinees were Han inhabitants in Changchun city. The informed consent was obtained from all subjects and the study protocol was approved by the ethics committee of the first affiliated hospital, Jilin University. The examinees received serum anti-IgG titre and pepsinogen examinations for screening infection and gastric atrophy. Tests for infection and diagnosis of gastric Atrophy Serum immunoglobulin (Ig) G antibodies to were detected by enzyme-linked immunosorbent assay (ELISA) using -IgG ELISA kit (Biohit, Helsink, Finland). The antibody titres were defined by optical density (OD) values according to the manufacturers protocol and titres higher than the cut off value of 30EIU, were considered as positive for infection. PepsinogenIand II (PGIand PGII) in serum were measured using ELISA kits (Biohit, Helsink, Finland). For screening gastric atrophy, we decided to use cut-off points of <82.3 ng/ml for PGIand <6.05.